Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
Go back to Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 12.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.34 | 52 Week High | $7.95 | |||
| Open | $12.34 | 52 Week Low | $0.40 | |||
| Day High | $12.34 | P/E | N/A | |||
| Day Low | $12.34 | EPS | $-5.33 | |||
| Volume | 219 | |||||

